Santhera Pharmaceuticals Holding Balance Sheet Health
Financial Health criteria checks 4/6
Santhera Pharmaceuticals Holding has a total shareholder equity of CHF59.9M and total debt of CHF20.9M, which brings its debt-to-equity ratio to 34.9%. Its total assets and total liabilities are CHF109.6M and CHF49.7M respectively. Santhera Pharmaceuticals Holding's EBIT is CHF51.2M making its interest coverage ratio 2.5. It has cash and short-term investments of CHF30.4M.
Key information
34.9%
Debt to equity ratio
CHF20.94m
Debt
Interest coverage ratio | 2.5x |
Cash | CHF30.37m |
Equity | CHF59.94m |
Total liabilities | CHF49.69m |
Total assets | CHF109.63m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SANNZ's short term assets (CHF34.7M) do not cover its short term liabilities (CHF44.3M).
Long Term Liabilities: SANNZ's short term assets (CHF34.7M) exceed its long term liabilities (CHF5.4M).
Debt to Equity History and Analysis
Debt Level: SANNZ has more cash than its total debt.
Reducing Debt: SANNZ's debt to equity ratio has reduced from 196.1% to 34.9% over the past 5 years.
Debt Coverage: SANNZ's debt is well covered by operating cash flow (225.7%).
Interest Coverage: SANNZ's interest payments on its debt are not well covered by EBIT (2.5x coverage).